Wedica-100mg( Trelagliptin )

Wedica ( Trelagliptin ) is indicated for type 2 diabetes.When the first line treatment of metformin is not achieving the expected glycemic goals. Wedica – The first global generic for Weekly Diabetic Care. Wedica controlling blood glucose levels. Wedica is available in tablet form for oral administration.

Category: Anti-Diabetic

Tags: Anti-Diabetic, Trelaglitin, Wedica

Wedica (Trelagliptin )

Product Description:

Wedica is a once-weekly dipeptidyl peptidase-IV (DPP-4) inhibitor. It controls blood glucose levels by selectively and continually inhibiting DPP-4, an enzyme that causes the inactivation of glucagon-like peptide-1 and glucagon-dependent insulinotropic polypeptide, incretin hormones* that play an important role in blood glucose regulation. The inhibition of DPP-4 increases insulin secretion depending on blood glucose concentration, thereby controlling blood glucose levels. Wedica is available in tablet form for oral administration.

Product Features:

Once Weekly Dose.

Lesser hypoglycemic events.

4 and 12-fold more potent than Alogliptin and Sitagliptin.

Product Name : Wedica

Generic Name : Trelagliptin Succinate

Formulation : Tablet

Available size : 2×8’s=16s

Strengths : 100mg